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Abstract
Bovine tuberculosis (bTB) is a chronic disease of cattle caused by Mycobacterium bovis, a member of the Mycobacterium
tuberculosis complex group of bacteria. Vaccination of cattle might offer a long-term solution for controlling the disease and
priority has been given to the development of a cattle vaccine against bTB. Identification of biomarkers in tuberculosis
research remains elusive and the goal is to identify host correlates of protection. We hypothesized that by studying global
gene expression we could identify in vitro predictors of protection that could help to facilitate vaccine development. Calves
were vaccinated with BCG or with a heterologous BCG prime adenovirally vectored subunit boosting protocol. Protective
efficacy was determined after M. bovis challenge. RNA was prepared from PPD-stimulated PBMC prepared from vaccinated-
protected, vaccinated-unprotected and unvaccinated control cattle prior to M. bovis challenge and global gene expression
determined by RNA-seq. 668 genes were differentially expressed in vaccinated-protected cattle compared with vaccinated-
unprotected and unvaccinated control cattle. Cytokine-cytokine receptor interaction was the most significant pathway
related to this dataset with IL-22 expression identified as the dominant surrogate of protection besides INF-c. Finally, the
expression of these candidate genes identified by RNA-seq was evaluated by RT-qPCR in an independent set of PBMC
samples from BCG vaccinated and unvaccinated calves. This experiment confirmed the importance of IL-22 as predictor of
vaccine efficacy.
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Introduction
Bovine tuberculosis (bTB) is a chronic disease of cattle caused by
Mycobacterium bovis, a member of the Mycobacterium tuberculosis
Complex group of bacteria. bTB is a significant economic burden
to the agricultural industries worldwide. It has been estimated that
more than 50 million cattle are infected worldwide with M. bovis
resulting in economic losses of approximately $3 billion annually
[1]. The incidence of bTB in Great Britain (GB) has been on the
increase since 1988 [2,3] and by 2010 approximately 10.8% of the
national herd were under TB restriction. Thus, in the last 10 year
£500 million have been spent to control bTB in England and it is
estimated that up to £1 billion will have to be spent over the next
decade in the absence of alternative control strategies. Consequent-
ly, the bTB control and eradication programs based on test and
slaughter policies will unlikely be sufficient without further control
measures. BCG vaccination of cattle induced protective immunity
to experimental bTB by reducing primarily the degree of pathology,
yet failed to induce more than 50% protection in the majority of
field experiments against natural infection [4]. Moreover, in cattle
BCG vaccination can induce protective immunity in some calves
that results in the resolution of M. bovis infection [5], a finding also
mirrored in humans infected with M. tuberculosis [6,7]. The most
promising vaccination strategies identified to date have mostly
involved improving upon BCG vaccination rather than replacing it.
BCG therefore remains the prototype vaccine against which to
judge the efficacy of any novel vaccine strategies. Several strategies
have been implemented to improve the efficacy of BCG, namely the
use of subunit vaccines in the form of DNA vaccines, protein subunit
vaccines administered with a suitable adjuvant, live recombinant
vaccines such as attenuated recombinant viruses expressing
mycobacterial antigens, or over-expressing genes in BCG that are
deleted or are under-expressed in BCG [8].
At present there are no reliable immunological correlates of
protection (i.e. predicting the success of vaccination after
completion of the vaccination protocol but before exposure to
the pathogen) for TB. The identification of such predictive
biomarkers would greatly facilitate the development of a vaccine
against bTB. Previous data from our group [5] and others [9,10]
have demonstrated that BCG vaccination of cattle induced an
immunological profile characterised by cell mediated immunity
with predominant and strong INF-c production.
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The successful development of a new vaccine against TB would
be greatly supported by reliable and well-defined predictors and
correlates of protection that would be use as go/no-go decision
gateway points for further candidate vaccine testing. In order to
identify biomarker patterns, it is essential to use tools that can
measure an integrated host response rather than isolated
characteristics of the adaptive immune response. The tools for
quantifying the changes in gene expression have been changing
with time and technological development, from limited capabilities
and time consuming methods (for example Northern blotting, RT-
PCR, SAGE) to effective, fast and high-throughput whole
transcriptome quantification using microarrays and new genera-
tion sequencing methods (NGS) [11].
Results
Characterisation of calves selected for RNA-seq analysis
In the first experiment, groups of 5 calves each were vaccinated
with BCG or with a heterologous prime-boost protocol of BCG
priming followed by Ad85 boosting. As expected, both BCG and
BCG/Ad5 vaccination resulted in significant protection against M.
bovis challenge compared to uninfected animals. Although a trend
towards improved protection using BCG/Ad5 was observed, this
difference was not statistically significant (Mean pathology scores
[6 SEM] for naı¨ve cattle, BCG and BCG/Ad85 vaccinated,
respectively: 12.3 [1.8], 7.2 [3.5], 5.6 [2.6]). As in previous
experiments, we also observed in each vaccine group animals that
were protected, i.e. presented without or with only minor visible
pathology at post-mortem, whilst other vaccinated animals showed
pathology undistinguishable from unvaccinated control animals.
Therefore we selected 4 animals across the vaccination groups that
were protected (2 BCG and 2 BCG/Ad85 vaccinated calves), 3
animals that were not protected (2 BCG and 1 BCG/Ad85A
vaccinated calves) and 3 animals from the unvaccinated control
group for the RNA sequencing experiment. The pathology scores
of the selected animals are shown in Figure 1A.
Heparinised blood from these animals was collected 14 weeks
post-BCG priming before M. tuberculosis challenge. PBMC were
prepared and stimulated with PPD-B. After 24 h culture,
supernatants were collected for IFN-c ELISA and RNA prepared
from cell pellets for transcriptome analysis by RNA-seq. As in
previous experiments, in vitro IFN-c production correlated well
with its transcription level [12,13] (Figure 1B). However, the IFN-
c responses of individual animals did not correlate with their
protection status again highlighting the need for additional
predictive markers of vaccine efficacy to complement IFN-c (data
not shown).
Definition of biomarkers of protection
Firstly, we prepared gene lists of those genes that were
significantly modulated (.2-fold change, p,0.05) after PPD-B
stimulation of PBMC from the three groups of animals. In total
240, 421 and 673 genes were up-regulated significantly in PBMC
from unvaccinated, vaccinated/un-protected, and vaccinated/
protected, respectively (Figure 2A). Interestingly, 295 of these
genes were significantly up-regulated exclusively in PBMC isolated
from the vaccinated/protected calves (Figure 2B). Amongst the
genes most strongly up-regulated in the group of protected animals
were those encoding IL-22, IFN-c, CCL3, IL-13, MT3, (see table
S1 for a full list of these genes).
In contrast, 218, 579 and 848 genes, respectively were down-
regulated after PPD-B stimulation of PBMC isolated from these
three groups (Figure 2A), with 373 of these genes exclusively and
significantly down-regulated in vaccinated and protected calves
(Figure 2B). Amongst the genes most down-regulated in vaccinat-
ed/protected calves were those encoding VCAM1, CXCL12 and
CCL14. A list of these 373 genes is provided in Table S1.
Figure 3 shows visualization of the expression of IL-22 and IFN-
c using Integrated Genome Browser (IGB, [14]) for one
representative PPD-B stimulated PBMC sample each from
vaccinated/protected, vaccinated/not-protected and control
calves. After sequencing, each of the reads was mapped against
the reference genome (Bos taurus) and the chromosomal positions of
the two genes are shown. The histograms represent the reads
mapped in their exact positions for ifn-c (Figure 3A) and il-22
(Figure 3B).
Functional analysis
Functional analysis using the DAVID Bioinformatics Database
was performed on the 668 genes that were significant regulated in
PBMC from vaccinated and protected calves. Of the 295 genes
that were significantly up-regulated the pathways most related
with this data set were the Cytokine-Cytokine Receptor Interac-
tion pathway (P= 2.8961026), Cell Cycle, p53 Signalling, and
Proteasome-Associated Pathways (all P,0.05) (Figure 4). On the
other hand, Prion Disease and Axon Guidance Pathways were
populated with down-regulated genes (P,0.05, Figure 4). Asso-
ciations that did not reach statistical significance were also
demonstrated with the Cytosolic DNA Sensing, Cancer and
Acute Myeloid Leukemia pathways (Figure 4). Figure 5 depicts the
genes and gene product interactions within the -Cytokine
Receptor Interaction pathway that were most significantly related
to protection. The genes encoding IL-22, IFN-c, CCL3 and IL13
were most strongly up-regulated (see also Table S1), again
highlighting the dominant role of IL-22 in protection.
Validation of the il-22 association with protection
To validate the results obtained from RNA-seq, we obtained
RNA samples from PBMC collected from an independent
experiment. This experiment (referred to as experiment 2 in the
methods section) comprised animals neonatally vaccinated with
BCG vaccinated that were 7 months later challenged with M. bovis
(n = 16) and an age-matched control group of naive calves (n = 8)
infected at the same time.
Author Summary
Bovine tuberculosis (bTB) is a chronic disease of cattle
caused by Mycobacterium bovis, a member of a complex
group of pathogens that also includes the bacterium
causing human tuberculosis, M. tuberculosis. Vaccination of
cattle might offer a long-term solution for controlling the
disease and priority has been given to the development of
a cattle vaccine against bTB. In addition to the relevance
for the veterinary field, cattle can also serve as useful pre-
clinical model for the development of human vaccines.
Identification of biomarkers in tuberculosis research
remains elusive and the goal of this study was to identify
host markers that allow the prediction of vaccine success.
In this experiment, the outcome of vaccination was
measured against relevant endpoints based on disease
severity. Our results, generated using the state-of-the-art
methodology of transcriptome sequencing defined a
dominant role of the cytokine IL-22 for predicting vaccine
success. We therefore identified a predictive biomarker
that can be used in future experiments and also
highlighted the role of T cells producing this cytokine in
protective immunity.
IL-22 Predicts Bovine Tuberculosis Vaccine Success
PLOS Pathogens | www.plospathogens.org 2 December 2012 | Volume 8 | Issue 12 | e1003077
Figure 1. Protection and in vitro IFN-c responses prior to challenge. A. Individual pathology scores are shown for the animals used in this
study. Naı¨ve animals = no vaccination, Vacc/NP= vaccinated calves that were not protected; Vacc/P = vaccinated calves that were protected. B.
Correlation of IFN-c protein production in culture supernatants measured by Bovigam ELISA (y-axis) and ifn-c gene expression as determined by deep
sequencing (x-axis). Data are shown from PPD-B stimulated PBMC from individual animals. Supernatants and RNA were prepared after 24 h culture.
doi:10.1371/journal.ppat.1003077.g001
Figure 2. Results of RNA-Seq analysis. A. Signficantly modulated genes in the three treatment groups. B. Venn diagrams of genes significantly
up-regulated and (C) down-regulated genes after vaccination but prior to M. bovis challenge. A. Fold change compared to unstimulated PBMC
(medium controls) of PPD-B stimulated PBMC compared to medium controls from unvaccinated, naı¨ve calves (group 1), vaccinated/non-protected
(group 2), and vaccinated/protected calves (group 3).
doi:10.1371/journal.ppat.1003077.g002
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The outcome of this experiment in respect to protective efficacy
is shown in Figure 6A. All BCG vaccinated animals in this
experiment were protected and we therefore compared the
transcription of il-22 from control animals with those obtained
from BCG vaccinated animals using RT-qPCR, transcription of
ifn-c was used as control. PBMC were prepared and stimulated
with PPD-B at 4 time points: Immediately prior to M. bovis
infection (week –1) and 2, 4, and 8 weeks post-challenge.
Confirming the results obtained by RNA-seq, il-22 was up-
regulated significantly after vaccination and prior to challenge
(Figure 6C, week –1, P,0.05) as was ifn-c. Interestingly, IL-22
transcription increased post-infection in the unvaccinated calves,
as we have previously shown [13]; a pattern that was mirrored in
the BCG vaccinated animals. Consequently, no differences
between il-22 transcription between the two groups were observed
post-M. bovis infection (Figure 6C). As it is possible that different
cell populations are producing IL-22 at the different time points
pre and post-challenge, we are currently phenotyping responder
populations. Data so far indicate, that at least in infected, non-
vaccinated cattle, IL-22 is transcribed exclusively in CD4+ T cells
[13]. As expected, transcription of ifn-c was also significantly
increased after vaccination (week –1, Figure 6B) as well as
immediately after infection (week 2) (P,0.05, Figure 6B). In
contrast ifn-c transcription in unvaccinated animals developed
slowly post-infection at week 4, and was significantly higher in
unvaccinated animals than in BCG vaccinated at week 8 post-
vaccination (P,0.05, Figure 6B). In summary, the results from this
independent experiment confirmed the role of il-22 transcription
in predicting protective immunity.
Discussion
The design and development of a new bTB vaccine, would be
greatly facilitated by the definition of predictors and correlates of
protection, which could potentially be identified by studying the
vaccine-induced host responses after vaccination and both before
and post M. bovis challenge. In particular, their definition would
allow rational vaccine design and testing thereby reducing the
costs of large animal experiments, as well as speeding up the
testing process, by selecting the most promising candidate vaccines
to be challenged with M. bovis in cattle BSL3 facilities. Such an
evidence-based gating strategy would allow a faster and more
informed rational approach to TB vaccine development. Howev-
er, the classic reductionist scientific approach in hypothesis
validation using conventional immunological methods has severe
limitations when it comes to scan, identify and define thousands of
potential biomarkers in parallel. Thus, systems biology, based in
the integration of data generated by –omics studies, has emerged as
Figure 3. BCG-vaccinated and control cattle samples mapped to ifn-c and il-22 genes. Visualization by IGB of RNA sequencing reads of
representative PPD-B stimulated PBMC from vaccinated-protected, vaccinate-un-protected and non-vaccinated control cattle. Y-axis shows the
number of reads covering each base along the transcript in RPKM expression values for each sample. Black track: unvaccinated control cattle; red
track: vaccinated/un-protected cattle and blue track: vaccinated/protected cattle. The schematic representation of transcript for (A) ifn-c and (B) il-22
is show in green at the bottom of the each figure; the boxes show the exons of the gene.
doi:10.1371/journal.ppat.1003077.g003
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a useful approach in order to identify gene signatures that can
predict and/or correlate with protection following vaccination
[15].
Although the immune response against TB is thought to be
based primarily on the key TH1 cytokine IFN-c, its induction
following vaccination does not necessarily demonstrate vaccine
success. However, absence of its expression after vaccination can
indicate the failure of the vaccine tested to protect against bTB
[8,9]. Thus, the expression of IFN-c following vaccination alone is
insufficient as a predictor of protection. In an earlier study, the
transcription of IL-17A predicted protection following vaccination
with BCG and correlated with protection after challenge with M.
bovis [12]. Although elevated IL-17A transcription was also found
in the present study in PPD-B stimulated PBMC from vaccinated/
protected compared to vaccinated/un-protected calves, the
differences did not quite reach statistical significance (data not
shown).
Another cytokine that is associated with a TH17 responses is IL-
22 [16] (although IL-22 can also be induced in an TH17-
independent manner by TH22, for example [17]), which is
involved in barrier surface protection and healing in skin, intestine
and lung [16]. In the present study, il-22 was the gene most up-
regulated in vaccinated/protected animals and thus constitutes a
surrogate of protection. To our knowledge, this is the first report
describing a role for IL-22 in vaccination against bTB. Previously,
it had been shown that IL-22 produced by NK cells in humans
and CD4+ T cells in macaques could limit M. tuberculosis growth in
macrophages by increasing phagolysosomal fusion [18,19]. How-
ever, IL-22 can play a dual role in tissue homeostasis depending on
the cytokine microenvironment where it is induced. For example,
Sonnenberg et al. showed that excessive pulmonary destruction
after intratracheal administration of bleomycin induced IL-22,
whilst in IL-17 2/2 mice, IL-22 showed tissue protective
properties [17]. Further, a murine model of allergic asthma using
OVA immunization in IL-22-deficient mice showed reduced lung
inflammation during the sensitization phase but increased lung
inflammation during the antigen challenge (inhibited by exoge-
nous IL-22) [20]. Thus, these opposing biological effects might
explain in part why IL-22 in our previous study was associated
with pathology in unvaccinated naturally infected cattle [13],
whilst in this study our data suggest that BCG vaccination induced
an adequate and balanced inflammatory and TH1/TH17 (or
TH22) cytokine response, with the expression of IL-22 in BCG
vaccinated cattle maintained at relatively stable levels after
infection compared with the increased observed in unvaccinated
controls at week 4 and 8 p.i., as demonstrated in our validation
experiment where we measured il-22 transcription also after M.
bovis challenge.
Besides the genes encoding for IL-22 and IFN-c a number of
other genes were strongly and significantly regulated exclusively in
vaccinated/protected calves. For example mt3, encoding the zinc
metallothionein MT-3 was the second most up-regulated gene in
Figure 4. Functional networks most significanty modulated in PPD-B stimulated PBMC from vaccinated/protected calves.
Visualisation of the trend and significance of each network: Red bars = up-regulation; blue bars = down-regulation of network. Horizontal bar: p = 0.05.
doi:10.1371/journal.ppat.1003077.g004
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this category after il-22. This protein is a zinc-binding protein
whose role in lysosomal function and autophagy of for example
neurons and astrocytes has been described [21]. Autophagy has
been linked with innate and adaptive immune responses against
intracellular pathogens including M. tuberculosis, and mt3 up-
regulation could reflect IFN-c induced macrophage activation.
Interestingly, the transcription of the TH2-associated cytokine il-
13 is also up-regulated, which is a cytokine that inhibits autophagy
alongside IL-4 [22]. The gene encoding for the chemokine CCL3
(MIP1a) was also found to be strongly up-regulated in PBMC from
protected calves. CCL3 is produced by innate cells as well as
CD4+ T cells during human TB (e.g. [23,24]). Its role after
vaccination may be to recruit antigen-specific T cells into the
airway lumen following infection with M. tuberculosis or M. bovis
[25]. Ccl3 in PPD-B stimulated PBMC may be a reflection of the
strong IFN-c responses induced.
In summary, although the development of TH1 responses
following vaccination is fundamental for TB vaccine success as has
Figure 5. Schematic representation of the genes involved in the cytokine-cytokine receptor interaction. Colour codes indicate genes
that were significantly modulated in vaccinated/protected calves prior to M. bovis challenge. Red colour: up-regulated genes; blue colour: down-
regulated genes. Darkness of colour indicates level of gene modification.
doi:10.1371/journal.ppat.1003077.g005
Figure 6. Gene expression in PPDB-stimulated PBMC from BCG vaccinated and control cattle. A. Protective efficacy after M. bovis
challenge determined by pathology scoring. Results are expressed as total pathology scores [5]. Filled circles, unvaccinated control calves; open
triangles, BCG vaccinated calves. (B, C). Transcription of the genes expressing IFN-c (B) and IL-22 (C) following in vitro stimulation. PBMC were
collected from BCG vaccinated (filled symbols) and controls (open symbols) before challenge (week -1) and after challenge with M. bovis at weeks 2, 4
and 8, and stimulated with PPD-B for 24 hours. cDNA was prepared and gene expression determined by RT-qPCR. Data are expressed as log10
relative expression levels compared to non-stimulated cells. Statistical analysis: 2-way ANOVA with Bonferroni post test, * P,0.05.
doi:10.1371/journal.ppat.1003077.g006
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been confirmed in this study by the significant modulation of IFN-
c expression as well as IFN-c induced genes, up-regulation of the
gene encoding il-22 as the dominant gene predicting vaccine
success has been the major finding of this study. Thus, induction of
TH17/22 subset responses alongside TH1 responses appears to be
important for the protective anti-tuberculosis response. However,
this biosignature needs to be prospectively validated in future
experiments to assess its full potentials for predicting protection.
Materials and Methods
Ethics
This study and all procedures were approved by the Animal
Health and Veterinary Laboratories Agency (AHVLA) Animal
Use Ethics Committee (UK Home Office PCD 70/6905) and
performed under appropriate personal and project licences within
the conditions of the Animals (Scientific Procedures) Act 1986. All
animals were housed in appropriate biological containment
facilities at the AHVLA.
Animals
Holstein-Friesian calves used in this study were recruited from
tuberculosis-free GB farms either neonatally or when around 6
months old. All animals were housed in appropriate biosafety
levels containment facilities and allowed access to food and water
ad libitum.
Vaccines
Mycobacterium bovis-Bacillus Calmette-Gue´rin (BCG) Danish
strain 1331 SSI (Serum Staten Institute, Copenhagen, Denmark)
was used for immunisations within 1 hour of vaccine reconstitu-
tion as per manufacturer’s instructions. The vaccine was prepared
fresh from lyophilised stock on the day of vaccination according to
the manufacture’s instructions and administrated subcutaneously
in a 0.5 ml volume. Each BCG vaccinated calf received the
equivalent of 5 human doses which on culture was determined to
be approximately 106 CFU. A recombinant human type 5
adenovirus expressing the mycobacterial antigen Ag85A (Ad85)
was used at 26109 infectious units/dose and applied via the
intradermal route [12].
Challenge and post mortem procedures
Calves were challenged with 2000 CFU M. bovis strain AF2122/
97 [26] by the endobronchial route. The infection inoculum was
grown to mid log phase in Middlebrook 7H9 broth supplemented
with 4.16 g/L pyruvic acid, 10% (v/v) oleic acid, albumin,
dextrose, and catalase (OADC) and 0.05% (v/v) Tween 80, and
subsequently stored at 280uC until being used in the experimental
infection experiments. At 9 or 12 weeks post-infection, cattle were
euthanized and underwent detailed post mortem examination; the
severity of the pathological changes after infection were scored
using the system described before [5].
Vaccination, blood collection and challenge schedules
Experiment 1: 6 months old calves were vaccinated with BCG as
described above; 8 weeks later, a subset of these animals was
boosted with Ad85. All animals were challenged 6 weeks later with
M. bovis AF2122/97 as described above and their disease status
determined 12 weeks later by post mortem examination as
described above. Blood was collected for analysis 14 weeks post-
BCG vaccination (and 6 weeks post-Ad85A boost) immediately
prior to M. bovis infection.
Experiment 2: Neonatal calves were vaccinated with BCG when
under 6 weeks old (as described above). 7 months later animals
were challenged with M. bovis AF2122/97 and their disease status
determined by post-mortem examination as described above.
Blood was collected 1 week prior to M. bovis infection and 2, 4, and
8 weeks post-challenge.
Bovine Peripheral Blood Mononuclear Cells (PBMC)
PBMC were isolated from heparinized blood collected before
M. bovis challenge by Histopaque-1077 (Sigma-Aldrich) gradient
centrifugation and resuspended at 26106/ml in tissue culture
medium (RPMI 1640 [Sigma] supplemented with 10% fetal calf
serum [Sigma], nonessential amino acids [Sigma], 100 U/ml
penicillin and 100 mg/ml streptomycin sulphate [Gibco]) and
incubated overnight with bovine tuberculin (PPD-B, 10 mg/ml,
Prionics, Schlieren, Switzerland) in 24-well tissue culture plates in
1 ml aliquots (Life Technologies). On the following day, plates
were centrifuged (3006g, 5 min at room temperature) and the
supernatants removed. For experiment 1, samples were responded
in 0.3 ml GTC (4 M guanidine thiocyanate, 25 mM tri-sodium
citrate pH 7, 0.1 M 2-mercaptoethanol, 0.5% Tween 80, 0.5%
sodium N-lauryl sarcosine). In experiment 2, 1 ml of Trizol
(Invitrogen) was added. Cell lysates were stored at 280uC.
DNA library preparation and sequencing
DNA library preparation and sequencing was done according to
manufacturer’s instruction using mRNA-Seq-8 Sample Prepara-
tion Kit (Illumina, San Diego, CA). Briefly poly-A containing
mRNA was isolated and purified from total RNA using poly-T
oligo-attached magnetic beads. The purified m-RNA was
fragmented using divalent cations at 94uC for 5 minutes. After
the first strand cDNA synthesis using reverse transcriptase and
random hexamer primers, the second strand cDNA synthesis was
performed using DNA polymerase generating double-stranded
cDNA. RNA was digested with RNaseH, then cDNA was purified
using QIAquick PCR Purification Kit (Qiagen). The purified
cDNA fragments were end repaired to convert the 59 and 39
overhangs into blunt phosphorylated ends using T4 DNA
polymerase and Klenow DNA polymerase before adding a single
‘‘A’’ base to the 39 end of the blunt phosphorylated cDNA
fragments using 39-to-59 exo-nuclease. Adaptors were ligated to
the ends of the cDNA fragments. Size selection was done using 2%
agarose gel. Approximately 200 bp cDNA was excised and gel
purified then enriched by PCR amplification for 15 cycles. Each
library was quantified using Agilent DNA 1000 kit (Agilent) on
Agilent 2100 Bioanalyzer. These libraries were denaturated using
NaOH and diluted to a final concentration of 6 pM. 100 ml of
these diluted libraries were used on Cluster Station using
Clustering Generation Kit v4 (Illumina). Sequencing was done
on Genome Analyzer IIx by singe end sequencing using a 36 Cycle
Sequencing Kit v4 (Illumina). Image analysis and base calling was
done using Genome Analyzer Pipeline software v1.5.0 (Illumina)
to generate raw fastq files.
The short sequence reads were assembled using the CLC
Genomics Workbench 4.7.2 RNA-Seq Analysis application using
the Bos taurus genome (Baylor4/bosTau4) [27] as reference with a
maximum of two mismatches and ungapped alignment. The
normalization of the assembled data was calculated with the reads
per kilobase of exon model per million reads (RPKM) [28] and
statistical difference in expression levels was calculated using
Baggerley test [29] using CLC Genomics Workbench. Only genes
that were significant regulated (p,0.05) more than62 fold change
were selected for pathway analysis using KEGG mapper [30], and
further analysis using the Database for Annotation, Visualization
and Integrated Discovery (DAVID) [31,32]. The raw data of the
IL-22 Predicts Bovine Tuberculosis Vaccine Success
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experiment was submitted to the NCBI Sequence Read Archive
(www.ncbi.nlm.nih.gov/sra/) with accession number SRA054204.
RNA extraction and Quantitative Real-time PCR
Total RNA was extracted from PBMC using TRIzol (Invitro-
gen) according to the protocol recommended by the manufacturer.
Turbo DNA-free (Ambion, Foster City, CA, USA) was used to
remove genomic DNA contamination. The purity and concen-
tration of RNA were evaluated by NanoDrop 1000 (Thermo
Scientific, Ottawa, Canada). cDNA from PBMCs was synthesized
from total RNA samples using random primers and reverse
transcription with Transcriptor High Fidelity reverse transcriptase
enzyme following the manufacturers protocol (Roche, Basel,
Switzerland).
Quantitative Real-time PCR. Transcripts were quantified
by qPCR with Fast SYBR Green master mix (Applied Biosystems
California, USA) following the manufactures instructions. qPCR
analysis was performed in triplicates using an ABI 7500 Fast Real
Time PCR System (Applied Biosystems California, USA). The
fold increase was calculated by comparison with the expression of
the endogenous controls genes SDHA, YWHAZ (bovine) [33] and
G3PDH using the 22DDct calculation [34,35].
Supporting Information
Table S1 List of genes significantly (p,0.05) modulated
in vaccinated and protected calves compared to naı¨ve
and vaccinated/unprotected animals. PBMC were isolated
from prior to M. bovis infection and stimulated with bovine PPD-B.
In ‘weighted proportions fold change’ column strength of red
colour indicate degree of up-regulated, of green, down-regulated
genes.
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